X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-02-23 | ONCT | Hale David F | Dir | P - Purchase | $9.04 | +980 | 31,304 | +3% | +$8,859 | ||||||
2024-02-23 | ONCT | Wills Robert James | Dir | S - Sale | $9.04 | -980 | 0 | -100% | -$8,859 | ||||||
M | 2023-06-12 | ONCT | Kaufmann Gunnar F. | Chief Scientific Officer | P - Purchase | $0.35 | +28,000 | 94,726 | +42% | +$9,824 | |||||
M | 2023-04-13 | ONCT | Breitmeyer James B | CEO | P - Purchase | $0.29 | +150,000 | 763,176 | +24% | +$43,930 | |||||
M | 2023-04-12 | ONCT | Yazji Salim | Chief Medical Officer | P - Purchase | $0.29 | +25,000 | 164,676 | +18% | +$7,200 | |||||
M | 2023-04-12 | ONCT | Leavitt Chase C. | GC, Secretary | P - Purchase | $0.29 | +25,000 | 106,901 | +31% | +$7,250 | |||||
2023-04-13 | ONCT | Vincent Richard G | CFO | P - Purchase | $0.30 | +30,000 | 163,219 | +23% | +$8,961 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |